BlackRock Fund Advisors - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 44 filers reported holding CLEVELAND BIOLABS INC in Q3 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q1 2014$89,000
-33.6%
129,967
+13.8%
0.00%
Q4 2013$134,000
-22.1%
114,193
+4.4%
0.00%
Q3 2013$172,000
+8.2%
109,413
+8.5%
0.00%
Q2 2013$159,000100,8090.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q3 2013
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,826,158$1,244,0000.07%
LADENBURG THALMANN FINANCIAL SERVICES INC. 721,200$507,0000.02%
Winfield Associates, Inc. 15,711$11,0000.01%
Van Cleef Asset Management,Inc 20,000$14,0000.01%
ACG Wealth 25,000$17,0000.01%
TAURUS ASSET MANAGEMENT, LLC 15,000$10,0000.00%
OPPENHEIMER & CO INC 25,500$17,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 500$341,0000.00%
BANK OF AMERICA CORP /DE/ 5,390$4,0000.00%
WELLS FARGO & COMPANY/MN 3,000$2,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders